We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

98 hedge funds and large institutions have $703M invested in Assembly Biosciences in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 37 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 11

95% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 19

63% more capital invested

Capital invested by funds: $432M → $703M (+$271M)

36% more funds holding

Funds holding: 72 → 98 (+26)

12% more call options, than puts

Call options by funds: $5.62M | Put options by funds: $5.03M

0.56% more ownership

Funds ownership: 5.94% → 6.5% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
98
Holders Change
+26
Holders Change %
+36.11%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
37
Reduced
19
Closed
11
Calls
$5.62M
Puts
$5.03M
Net Calls
+$589K
Net Calls Change
+$2.45M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17M
2
Jennison Associates
Jennison Associates
New York
+$13.1M
3
FCM
Farallon Capital Management
California
+$9.43M
4
Invesco
Invesco
Georgia
+$9.29M
5
EA
Emerald Advisers
Pennsylvania
+$7.23M

Top Sellers

Rank Fund Capital Flow
1
VFA
Valeo Financial Advisors
Indiana
-$4.96M
2
QF
QVT Financial
New York
-$1.86M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.69M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$990K
5
LSC
Lyon Street Capital
California
-$905K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
Bogle Investment Management
Massachusetts
$4.02M +$3.35M +7,402 New
TCIM
27
TIAA CREF Investment Management
New York
$3.27M +$870K +1,922 +47%
ZIM
28
Zacks Investment Management
Illinois
$3.26M +$2.71M +5,997 New
OAM
29
Oxford Asset Management
United Kingdom
$3M +$21.7K +48 +0.9%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.89M +$622K +1,375 +35%
PP
31
PDT Partners
New York
$2.24M +$1.06M +2,331 +130%
HSBC Holdings
32
HSBC Holdings
United Kingdom
$1.83M +$1.52M +3,366 New
EI
33
EAM Investors
California
$1.7M +$905K +1,999 +177%
ARTA
34
A.R.T. Advisors
New York
$1.67M +$1.39M +3,077 New
AQR Capital Management
35
AQR Capital Management
Connecticut
$1.66M +$860K +1,899 +163%
Deutsche Bank
36
Deutsche Bank
Germany
$1.6M -$828K -1,830 -38%
Morgan Stanley
37
Morgan Stanley
New York
$1.6M -$96.9K -214 -7%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$1.55M +$1.24M +2,743 +2,406%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$1.55M -$48.9K -108 -4%
Victory Capital Management
40
Victory Capital Management
Texas
$1.52M +$446K +985 +54%
Charles Schwab
41
Charles Schwab
California
$1.42M +$302K +667 +34%
TA
42
Teachers Advisors
New York
$1.31M +$152K +336 +16%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.29M +$18.6K +41 +2%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.28M +$1.07M +2,358 New
EGI
45
EAM Global Investors
California
$1.22M +$1.02M +2,253 New
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$1.22M -$611K -1,349 -38%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.15M +$112K +247 +13%
Federated Hermes
48
Federated Hermes
Pennsylvania
$1.01M +$280K +618 +50%
Group One Trading
49
Group One Trading
Illinois
$935K +$779K +1,721 New
SO
50
STRS Ohio
Ohio
$855K -$143K -317 -17%
1
2
3 4 5

ASMB Hedge Fund Activity: Q4 2017 in Review

98 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2017, worth a combined $703M — up 63% from $432M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASMB positions and 11 closed out — a net gain of 26 holders — while 37 added to existing stakes and 19 trimmed.

The largest buyer was OrbiMed, adding an estimated $17M. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $4.96M sold.

  • 98 institutional investors held Assembly Biosciences (ASMB) as of Q4 2017, up from 72 in Q3 2017.
  • Funds reported $703M of Assembly Biosciences stock for Q4 2017, up 63% quarter-over-quarter.
  • 37 funds opened new Assembly Biosciences positions in Q4 2017 and 11 closed out, a net change of +26 holders.
  • The largest Assembly Biosciences buyer in Q4 2017 was OrbiMed, an estimated $17M added.
  • The largest Assembly Biosciences seller in Q4 2017 was Valeo Financial Advisors, an estimated $4.96M sold.

Based on aggregated 13F filings for Q4 2017.